On the eve of Lunar New Year, the outbreak of novel coronavirus told hold of Wuhan, Hubei Province and quickly spread to other regions. While prevention and control work was carried out across China in accordance with relevant measures suggested by State Council of the People'...s Republic of China, China Resources Group headquarters and subsidiaries immediately called for action to establish effective internal control against risks and provided medical personnel to support...

1.Shanghai MixC Tower Phase One Fund has successfully exited, and CR Capital Management partnered with CR Land to yield positive result

In January 2019, CR Capital Management’s Shanghai MixC Phase One Fund has successfully exited. The acquisition of its 4 Grade A office towers and ancillary commercial buildings of Shanghai MixC was officially completed on 7 January. The fund was set up at the end of 2013, with China Resources Capital Management as the fund manager, China ...

The 2nd China International Import Expo was held at the National Exhibition and Convention Center (Shanghai) in 5-10 November. CR trade team, led by Mr. Wang Chuncheng, Vice General Manager of China Resources Group participated in the event. China Resources Group signed purchase agreements and forged co-operations with 17 overseas companies at the Expo, covering industries and products including consumer, high-end manufacturing and high-tech materials.

On 24-25 September, 60 delegates from the Belt and Road News Alliance Class visited Guangzhou CRC Thermoelectricity Limited Company, Pacific Coffee Company and Olé Supermarket to gain an in-depth understanding of China Resources’ implementation in business innovation and green development.

On June 25, CR Healthcare, Mitsui & Co., Ltd and Hopu Investments held the signing ceremony of the CMH Heath Fund cooperative agreement at China Resources Building in Hong Kong. China Resources’ Chairman Fu Yuning and General Manager Wang Xiangming, Mitsui’s Representative Director Tatsuo Yasunaga and Southeast Asia Representative Motoo Ono, as well as Hopu Investments’ Chairman Fang Fenglei and Chief Executive Officer Liu Dexian jointly officiated at the event and reached b...

On April 24-25, the Chairman of China Resources Group, Dr. Fu Yuning attended the Belt and Road CEO Conference upon invitation in Beijing. The large-scale and high-profile Conference was held for the first time by the Belt and Road Forum for international cooperation, attracting nearly 900 representatives from countries around the world.

On the morning of April 11, a ceremony was held to mark the opening of the St. Regis Hong Kong, invested and built by China Resources Group (CRG). The ceremony was attended by over 100 guests including CRG leaders such as Chairman Dr. Fu Yuning and General Manager Mr. Wang Xiangming, the management team of the St. Regis Hong Kong Project, the head of the Marriott International Group, the hotel management team, and related partners and customer representatives.

China Resources Groups'... Pacific Coffee and Hong Kong College of Technology (HKCT) jointly launched the “Beyond Dreams – First Entrepreneurial Training program of Pacific Coffee x HKCT @ the Greater Bay Area” on March 8th, 2019. The program is intended to help Hong Kong young people who are interested in starting businesses in the area get familiar with work and life before having their dreams fulfilled to become part of the country’s development story. The program is the...

Group Chairman Fu Yuning led a delegation to the Netherlands, Spain and Denmark for a business visit from February 23 to March 3, 2019. During the visit, the delegation researched world leading pension institutions such as Buurtzorg Nederland, as well as food and beverage companies including Heineken, AMC and Tetra Pak, talked about strategic cooperation with these companies and achieved satisfying results.

A ceremony was held to mark the signing of an agreement between China Resources Group (CRG) and Charoen Pokphand Group (CP Group) to jointly launch the Life Sciences Fund on January 28, 2019. The Fund will be directed to innovative health-related technological products or services, including diagnosis, devices, therapies, medicine and technology, combined devices, and data-assisted systems, etc. Taking advantage of the shareholders’ strengths in pharmaceutical and medical fi...